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Abstract
Background: Adolescent depression is common and impairing. There is an urgent need to develop early
interventions to prevent depression becoming entrenched. However, current psychological interventions are
difficult to access and show limited evidence of effectiveness. Schools offer a promising setting to enhance access
to interventions, including reducing common barriers such as time away from education. Distressing negative
mental images and a deficit in positive future images, alongside overgeneral autobiographical memories, have
been implicated in depression across the lifespan, and interventions targeting them in adults have shown promise.
Here, we combine techniques targeting these cognitive processes into a novel, brief psychological intervention for
adolescent depression. This feasibility randomised controlled trial will test the feasibility and acceptability of
delivering this imagery-based cognitive behavioural intervention in schools.
Methods/design: Fifty-six adolescents (aged 16–18) with high symptoms of depression will be recruited from
schools. Participants will be randomly allocated to the imagery-based cognitive behavioural intervention (ICBI) or
the control intervention, non-directive supportive therapy (NDST). Data on feasibility and acceptability will be
recorded throughout, including data on recruitment, retention and adherence rates as well as adverse events. In
addition, symptom assessment will take place pre-intervention, post-intervention and at 3-month follow-up.
Primarily, the trial aims to establish whether it is feasible and acceptable to carry out this project in a school setting.
Secondary objectives include collecting data on clinical measures, including depression and anxiety, and measures
of the mechanisms proposed to be targeted by the intervention. The acceptability of using technology in
assessment and treatment will also be evaluated.
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Discussion: Feasibility, acceptability and symptom data for this brief intervention will inform whether an efficacy
randomised controlled trial is warranted and aid planning of this trial. If this intervention is shown in a subsequent
definitive trial to be safe, clinically effective and cost-effective, it has potential to be rolled out as an intervention
and so would significantly extend the range of therapies available for adolescent depression. This psychological
intervention draws on cognitive mechanism research suggesting a powerful relationship between emotion and
memory and uses imagery as a cognitive target in an attempt to improve interventions for adolescent depression.
Trial registration: ISRCTN85369879
Keywords: Depression, Adolescence, Mental imagery, Autobiographical memory, Early intervention, Psychological
therapy
Background
Depression is common and costly, with adolescence be-
ing a crucial period for its onset and long-term impact
[1]. The peak age of first onset of depression is in ado-
lescence, with onset during adolescence (rather than
adulthood) associated with more recurrences and an in-
creased risk of chronicity [2, 3]. Adolescent depression
impacts on functioning, being associated with higher so-
cial dysfunction, poorer academic performance, more
physical ill health complaints and more completed sui-
cides [4–6]. Intervention during the early stages of de-
pression may prevent the long-lasting and severe
outcomes associated with it (as well as prevent the de-
velopment of secondary disorders) [3]. Yet, current early
interventions are difficult to access [7] and lack convin-
cing evidence of effectiveness [8]. Access could be im-
proved by delivering interventions in school settings to
reduce barriers of time and cost [8–10], and targeting
the underlying mechanisms that drive depression could
reduce risk for future relapse. Two promising new treat-
ment targets are mental imagery and autobiographical
memory specificity. These targets are suggested from
evidence that people with depression frequently experi-
ence past distressing images, struggle to imagine positive
events in their future and do not recall memories in de-
tail [11–15]. Adolescence is a key period to target these
processes, given that depressive symptoms commonly
begin in adolescence, cognitive factors are likely to sta-
bilise during this time and adolescents may harness im-
agery techniques more readily than verbal approaches.
We have developed a novel and brief intervention that
targets both mental imagery and autobiographical mem-
ory through a series of exercises. The simple and manua-
lised format has a potential for future scalability, since it
may not require an expert therapist to administer. Here,
we aim to investigate whether such an early intervention
is feasible and acceptable in a feasibility randomised con-
trolled trial (RCT). We will also gather descriptive data on
changes in symptoms and the proposed mechanisms, as
well as evaluate the role that technology could play in en-
hancing assessment and intervention for this population.
Mental imagery
Mental images range from distressing memories of past
events, entering awareness unbidden and producing
strong psychophysiological stress responses (i.e. intru-
sions) to images of possible future events deliberately
brought to mind (e.g. when planning) [11]. Mental im-
agery can be positive or negative and, unlike verbal
thoughts, is characterised by having close access to sen-
sory information, being as if ‘seeing with the mind’s eye
or hearing with the mind’s ear’ [16]. In adults, depres-
sion is associated with both an increased frequency of
distressing intrusive images and a deficit in generating
positive future imagery [13, 15, 17–20]. Whilst these
associations have mostly been demonstrated in adults,
there is increasing evidence also documenting these
relationships in adolescence [14]. A number of tech-
niques have been explored to target mental imagery,
including imagery rescripting to process distressing
negative images and techniques to enhance positive
imagery. Both techniques have demonstrated promising
results in depression and other disorders in adults
[21–26]. The current intervention aims to transform
negative images and challenge the meaning associated
with a non-traumatic negative life event as well as
enhance the vividness and positive emotional response
to positive images.
Targeting imagery in adolescence could be particularly
developmentally appropriate. Compared to adults, ado-
lescents may rely more generally on imagery for process-
ing and skill acquisition [27]. Moreover, in response to
extreme stressors, factors that change during develop-
ment (such as encoding, emotional regulation, memory
retrieval) may mean that young people are less able to
cognitively process stressful experiences compared to
adults [14, 28, 29], perhaps putting them at higher risk
for developing intrusive images. Studies have demon-
strated that non-traumatic stressful life events in youth
(such as bullying) can have long-term adverse effects on
mental health and these events can enter awareness as
distressing negative images [14, 30]. Indeed, distressing
recurrent mental images linked to disorder onset
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frequently begin in adolescence [31]. Therefore, imagery
interventions could be particularly suited to this period
of cognitive development, with adolescence representing
a balance between heightened reliance on image-based
processing (relative to adults) and greater degree of cog-
nitive control over emotional mental imagery (relative to
children). More generally, adolescence represents a
period of increased flexibility and learning potential.
This may mean negative experiences, such as depression,
alter developmental trajectories resulting in long-lasting
maladaptive changes that persist into adulthood [32–35].
Yet, due to this greater plasticity, adolescence could also
be a key period of opportunity to prevent chronic de-
pression developing.
Memory specificity
Autobiographical memory relates to the ability to recol-
lect facts and personal events from one’s life [36]. The
specificity of this recollection is variable across people.
Specific memories identify unique events, occurring at a
particular time and place, and are in contrast with mem-
ories that are of repeated events (categorical memories)
or events that last longer than a day (extended memor-
ies) [19]. Overgeneral memory (OGM) is a phenomenon
where individuals have difficulty retrieving specific auto-
biographical memories and instead generate categorical
or extended memories. Autobiographical memory is im-
portant for the individual’s sense of self and their daily
functioning. Difficulties in accessing and processing spe-
cific autobiographical memory impact on daily cognitive
functioning, including planning, problem-solving and
social interaction [20] as well as difficulties imagining
future events [37].
OGM has been consistently implicated in adolescent
depression, being not only associated with current symp-
toms but also with the onset, maintenance and relapse
of depression [38]. Research in adults has further dem-
onstrated that OGM is predictive of developing depres-
sion [39] and of later depression severity, even when one
is not currently depressed [40]. Researchers suggest that
people may try to avoid the details of a negative event in
order to control their response to it and that this re-
duces specificity across positive and negative memories
[19]. For example, the experience of childhood abuse is
associated with OGM in young people [41], and OGM
predicts depression severity following trauma in adults
[42]. Importantly, research with adults has demonstrated
that OGM does not reflect a general deficit in memory
functioning [19] and is not purely a correlate of current
low mood [43]. Early-stage trials in adolescents and
adults indicate that a simple approach to increase mem-
ory specificity (generating specific memories to cue
words, e.g. happy) can reduce depressive symptomatol-
ogy and improve day-to-day cognition [24, 44, 45].
Aims of IMAGINE trial
Here, we have combined techniques of imagery rescripting
for negative events, image generation for positive events
and memory specificity training to produce a novel early
intervention for adolescent depression. The intervention
is brief, manualised and clearly structured which will fa-
cilitate future scalability through delivery by practitioners
without extensive training. The primary aim of the IM-
AGINE (Integrating Memories And Generating Images of
New Experiences) trial is to investigate whether it is feas-
ible and acceptable to carry out a RCT of this novel inter-
vention (compared to a suitable control condition)
successfully within a school setting. Given that a future
trial would need to assess whether the proposed active
components of the imagery-based cognitive behavioural
intervention are contributing to any change (rather than
other non-specific therapist factors, such as empathy and
active listening), the comparison intervention will include
non-specific therapist factors. The secondary aim is to col-
lect pilot data on clinical measures as well as on the
underlying mechanisms proposed to be targeted in the
intervention. This will include measures of imagery vivid-
ness, emotional response to a positive memory and mem-
ory specificity. Finally, the trial will also assess the
feasibility and acceptability of incorporating technology
into assessment and the intervention.
Methods/design
Study design and timeline
This study is a feasibility randomised controlled trial with
parallel groups, conducted across multiple schools in the
United Kingdom (UK). Both groups will receive active in-
terventions, and both interventions aim to improve mood
and self-esteem. Participants will be assessed at pre-
intervention (prior to randomisation), and follow-up as-
sessments will take place after the intervention and a
briefer assessment completed 3 months following the end
of the intervention (see Figs. 1 and 2). These methods are
based on the IMAGINE trial protocol (version 1; 1 April
2017), approved by the trial steering committee.
Study population
Inclusion criteria
1. Aged 16–18 (a narrow age range was chosen to
reduce heterogeneity between the groups, for
example to reduce the influence of individual
differences in maturational and experiential factors).
2. Informed consent (obtained by the assessor during
the pre-intervention assessment).
3. Willing and able to engage in psychological
intervention and complete assessments.
4. Scoring above 20 on the Mood and Feelings
Questionnaire (MFQ of 33 items) in the pre-
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intervention assessment. The MFQ has 70% sensi-
tivity and 81% specificity for discriminating any
mood disorder [46]. A score of 20 is based on simi-
lar previous studies [47] and trial protocols [48].
Exclusion criteria
1. Diagnosis of learning disability or significant head
injury, neurological disorder or epilepsy.
2. Unable to fluently communicate in English.
3. Unable to give informed consent.
4. Factors contra-indicating imagery rescripting, i.e. high
levels of current risk. This will be verbally assessed with
the participant in the pre-intervention assessment.
5. Currently receiving another psychological
intervention (including school counselling).
6. Experiencing distressing psychotic symptoms or
depressed in the postnatal period (participants with
Fig. 1 IMAGINE trial flowchart
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comorbid physical illness or non-psychotic disor-
ders, such as anxiety, will not be excluded).
Sample size
A power calculation to determine the sample size is not
appropriate for a feasibility trial, as the purpose of the
trial is not to establish efficacy at this stage. However,
the data from this trial could be used to provide initial
estimates of the likely range of effect sizes for the inter-
vention. The target recruitment for this feasibility trial
will be N = 56 (28 in each arm). This was determined
with reference to good practice recommendations for
feasibility studies, which recommend sample sizes of be-
tween 24 and 50 [49–51]. The sample size of 50 was in-
flated to allow for drop-out following randomisation,
which was estimated to be 10% based on similar studies
[47] identifying a final sample size of 56.
Recruitment, randomisation and blinding
All participants will be recruited from secondary schools
and sixth form colleges in the UK. For the screening
stage, information sheets will be provided and young
people asked to complete the Mood and Feelings Ques-
tionnaire (MFQ, at screening the four risk items will be
removed from the MFQ due to ethical considerations).
Eligible participants will be contacted and provided with
the information sheet for the intervention stage. Young
people will be given at least 24 h to read over the
information and consider taking part, as well as discuss
their participation with anyone they may wish to (e.g.
parent). The first assessment will then be completed at
the young person’s school, which will include adminis-
tering the MFQ again (33-item version) and confirming
the other eligibility criteria. Once the young person has
given informed consent, the full pre-intervention assess-
ment will be administered. Whilst parental consent will
not be sought, since all participants will be over age 16,
we will follow each school’s recommendations for con-
tacting parents and discussing participation. Examples of
this might be contacting the parents by phone, email or
letter and providing information about the trial and the
opportunity to contact the team and discuss the study.
A number of strategies attempting to enhance recruit-
ment and retention have been incorporated; these in-
clude recommendations from service user consultants to
deliver the intervention in schools, to ask young people
about the best way to contact them to discuss the pro-
ject and to not complete formal diagnostic assessments.
Furthermore, specific strategies will be discussed with
individual schools as to how best to recruit young people
and retain them in the trial.
Following the assessment, participants will be ran-
domly allocated to one of two interventions by the
King’s Clinical Trials Unit (KCTU). Participants will be
randomised in a 1:1 ratio using block randomisation via
a web-based system. The sample will be stratified by
Fig. 2 SPIRIT figure for IMAGINE trial
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school. Randomly varying block sizes will reduce the
predictability of the sequence and ensure allocation con-
cealment. The control intervention is a recommended
Tier 2 intervention, which helps to address potential
ethical issues related to randomisation. The randomisa-
tion system will be accessed by the chief investigator
(VP) via the web interface in the time period between
the pre-intervention assessment and first intervention
session.
A double-blind design is not possible due to the nature
of the intervention under investigation (the young per-
son will be aware of which intervention they have re-
ceived, as will the therapist administering it). However,
as both experimental and control interventions are cred-
ible therapeutic interventions, this should help reduce
any potential bias associated with expectations of the
benefits of the intervention. The two interventions will
be referred to as intervention 1 and intervention 2, and
both will be described as ‘programmes aiming to im-
prove low mood and self-esteem’ in all participant and
staff literature in order to promote equal intervention
credibility between the conditions. That is, participants
are not informed as to what is the ‘new’ intervention in
order to avoid potential imbalances in expectancy. All
reasonable attempts will be made to keep school staff
blind as to which intervention participants have been
randomised to.
VP will be primarily responsible for gathering the
data and will conduct both therapeutic interventions.
Assessments will be completed by appropriately
trained individuals, independent from the clinical
team (e.g. research assistants and postgraduate stu-
dents), who will be blind to intervention allocation.
Participants who drop out or discontinue the inter-
vention will still be invited to complete the assess-
ment sessions. For clinical data collection, risk of
assessor bias will also be reduced by choosing mea-
sures that are less susceptible to bias and by using
multiple measures. Good Clinical Practice guidelines
for clinical trials will be followed [52].
Interventions
Both interventions will consist of three to four indi-
vidual sessions with VP. Four sessions will be offered
to young people taking part in the trial, and sessions
will be re-arranged where possible. Successful comple-
tion of the intervention is defined as not missing
more than one intervention session (i.e. completing
three sessions). It is anticipated that the most likely
reason for young people attending three rather than
four sessions is that they miss one session and then
there not being sufficient time remaining in the
school term to re-arrange.
Experimental intervention: imagery-based cognitive
behavioural intervention
The intervention will follow a written treatment manual
and is accompanied by a workbook. The intervention
will combine (A) imagery rescripting to reduce the dis-
tress associated with certain negative images and build
positive future images and (B) memory specificity train-
ing to increase specificity and access to memories. The
intervention is based on cognitive behavioural principles
and experimental psychopathology research on mental
imagery and emotion. An overview of the intervention is
outlined below:
1. Rationale for ‘training memories’, including the role
of memories and relationship between memories/
images, mood and behaviour.
2. Imagery rescripting for a negative past image (e.g. a
negative experience in school). The procedure will
be based on previous adult literature where
participants visit the memory in three stages [23,
53, 54]. Unlike the adult literature, this intervention
is not aiming to rescript trauma memories.
Participants will be asked to choose an image that is
negative that they have thought about recently and
that is associated with school (for example failing
an exam or an argument with friends).
3. Scripting positive future imagery (e.g. graduating
from university) using a similar protocol as above,
adapted for future goals.
4. Rationale and practice for making memories more
specific and detailed. Specificty training will include
in-session exercises and homework tasks delivered
using daily prompts (e.g. participants will be asked
to generate a memory to a cue word).
Control intervention
A structured control intervention, based on previous
studies [55–57], will be delivered. This will consist of
‘non-directive supportive therapy’ (NDST) as this is the
NICE recommended treatment for depression in Tier 2
[57]. NDST involves the planned delivery of individual
sessions with an empathic, concerned professional for
emotional support, discussion of participant-initiated op-
tions for addressing problems and monitoring (e.g. de-
pressive symptoms). Participants in the NDST arm will
be offered the same number and frequency of sessions
as those in the imagery-based cognitive behavioural
intervention (ICBI) arm. This intervention is designed to
control for factors that, other than active components of
therapy, could contribute to change, such as passage of
time and non-specific aspects of therapy (e.g. speaking
to an empathic therapist). The intervention will follow a
written treatment manual.
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Treatment fidelity
Sessions will be audio recorded (if the young person
consents). A sample of these sessions will then be
assessed for adherence to the intervention manuals by
an independent rater. The rater will assess the audio re-
cordings for both adherence and competency, according
to a modified version of the cognitive therapy scale [58].
Ratings of adherence to the manuals will also indicate
whether there has been contamination between the con-
ditions from the therapist having knowledge of both
interventions.
Outcome measures
Primary objective—feasibility/acceptability data (see Fig. 1)
Number of eligible participants, willingness of
schools and participants to take part and be
randomised
1. Recruitment throughout trial.
 Number of schools that are approached and
number of schools agreeing to take part (as well
as proportion of total schools that are
approached).
 Number of young people potentially eligible to
complete screening questionnaire.
 Number (and proportion of relevant total) of
participants that complete the screening stage.
 Number of eligible participants at screening and
at pre-intervention assessment as well as propor-
tion of total.
 Number (and proportion) of ineligible
participants at screening and at pre-intervention
assessment (and reasons for this).
 Number (and proportion) of participants
consented to take part in the intervention.
 Number (and proportion) of participants
randomised.
2. Number of participants successfully completing
intervention and reasons for non-completion (suc-
cessful completion is defined as not missing more
than one intervention session).
 Number (and proportion) of participants who
drop out and reasons for this. (In line with our
ethical informed consent procedure, participants
can discontinue or withdraw from the study at
any time without giving a reason. Reasons for
discontinuation/withdrawal will be recorded
when possible.)
Follow-up rates, response rates to questionnaires, ad-
herence/compliance rates
1. Data on retention at each time point (pre-
intervention, post-intervention and 3-month follow-
up assessments).
2. During the intervention: range and average number
of sessions completed (including number of sessions
attended as a proportion of those offered).
3. Follow-up: numbers and proportion of participants
completing follow-up and numbers not completing
with reasons.
4. Independent rating of adherence to intervention
manual/protocol (see above for details).
Data completeness Data completeness for each ques-
tionnaire will be summarised, i.e. number of participants
completing each questionnaire at each time point.
Unexpected adverse effects Any unexpected adverse
effects of participating in the trial will be recorded.
Acceptability of the intervention Responses to a feed-
back questionnaire asking participants about their ex-
perience of the intervention will be recorded. The
feedback questionnaire includes questions with rating
scales and questions with written responses.
Secondary objective—collect data on clinical measures
Questionnaire measures of depression, anxiety and self-
esteem as well as questionnaires and tasks that measure
the proposed mechanisms of therapeutic change will be
included. All measures are administered at each of the
three assessment time points, except the ‘daily mood rat-
ings and social connectedness’ and the ‘memory recall
task’ which are only administered at pre-intervention
and post-intervention time points.
1. Mood and Feelings Questionnaire (MFQ). The
MFQ [59] is a self-report measure of depression.
The long version of the MFQ (33 items rated on a
3-point Likert scale from 0 to 2) will be used at
each of the three assessment time points and is the
primary clinical measure for this trial. Scores range
from 0 to 66 with higher score indicating more
symptoms of depression. The MFQ has been used
extensively in research and community settings; it is
recommended by the National Institute of Clinical
Excellence [57] and is routinely used in Child and
Adolescent Mental Health services in the UK. The
MFQ has been shown to be reliable and valid with
scores of over 29 indicating a likely current major
depressive episode and scores of over 20 indicating
the presence of ‘any mood disorder’ [46]. For the
screening stage, the four risk items will be removed
from the MFQ due to ethical considerations in
mass testing conditions. The MFQ at the screening
stage will therefore consist of 29 items and a clinical
cut-off score of 17 will be used at screening to re-
flect this. The shorter version (12 items) will also be
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administered at the beginning of each intervention
session alongside a risk item to monitor any change
in risk. The shorter version is preferred for inter-
vention sessions given its quicker completion time.
2. Screen for Child Anxiety Related Disorders
(SCARED). The SCARED [60] is a self-report meas-
ure of anxiety. The SCARED consists of 41 items,
rated on a 3-point Likert scale from 0 to 2. Total
scores on the measure range from 0 to 82 with
higher scores indicating more anxiety. The SCARED
also has five subscales: panic disorder or significant
somatic symptoms, generalised anxiety disorder,
separation anxiety, social anxiety disorder and sig-
nificant school avoidance. The SCARED shows ex-
cellent internal consistency, test re-test reliability,
and concurrent and discriminate validity [60, 61].
3. Revised Impact of Event Scale: child version (RIES-
C). The 13-item self-report version of the RIES-C
[62] will be administered to measure post-traumatic
stress symptoms in reference to a negative event.
Items are rated on a 4-point Likert scale (measured
0, 1, 3, 5) with higher scores indicating more symp-
toms of post-traumatic stress. There are also three
subscales on the RIES-C: intrusion, avoidance and
arousal. The RIES-C has been established as a good
screen for PTSD diagnosis [62] with good internal
reliability (Cronbach’s α = .80 [63]). The RIES-C also
includes a single-item measure of intrusive image
frequency.
4. Children’s Response Style Questionnaire (C-RSQ).
The C-RSQ [64] measures cognitive responses to
low mood using 25 items. It is a self-report measure
with three subscales: ruminative responses, distrac-
tive responses and problem-solving responses.
Young people are asked to rate how frequently they
use certain responses to low mood. Items are rated
on a 4-point Likert scale (measured 1 to 4) with
higher scores indicating a greater tendency to en-
gage in that response style. Previous studies have
demonstrated good validity and good internal
consistency [64, 65].
5. Rosenberg Self Esteem Scale (RSES). The RSES [66]
is a ten-item self-report measure of self-worth.
Scores range from 1 to 4 with higher scores indicat-
ing greater self-esteem. The RSES is widely used
across the age range, and previous studies have
demonstrated reliability, validity and good internal
consistency in an adolescent sample [67–69].
6. Self-Concept Clarity scale (SCCS). The SCCS [70]
measures a person’s confidence in being able to
define themselves clearly. It is a self-report measure
consisting of 12 items rated on a 5-point Likert
scale (scored 1 to 5), with higher scores indicating
greater self-concept clarity. Previous studies have
demonstrated the validity and reliability of the
SCCS [70], and it has been used in an adolescent
population [71].
7. The Prospective Imagery Task (PIT). The adult
version of the PIT [13, 17] has been adapted for use
in young people. Participants are asked to read 14
scenarios, which includes 7 negative and 7 positive
scenarios (e.g. ‘You will make good and lasting
friendships’). Participants are asked to imagine each
happening to them and then rate the vividness of
the generated mental image on a 5-point scale
(from 1 to 5). In addition to the adult version, par-
ticipants will also be asked to specify how often
they have had this image before on a 5-point scale
(from 1 to 5). Higher scores indicate more vivid or
frequent images of the future on the two scales.
8. Autobiographical Memory Task (AMT). The AMT
[72] will be administered to measure memory
specificity, following Williams and Broadbent
procedure and coding scheme. Participants are
asked to give a specific memory to ten cue words
(five positive; five negative), presented in a randomised
order orally and in writing (printed on index cards).
Participants are given 60 s to respond to each cue
word. Before beginning, participants are given the
opportunity to practise two cue words (beach and egg)
and are given feedback on their responses. Each
memory will be coded as (1) ‘specific’ if the memory
was of an event occurring at a particular place and
time and lasting less than a day, (2) ‘general
categorical’ if the memory was of a repeated event, (3)
‘general extended’ if the memory referred to an event
that lasted longer than a day, (4) ‘semantic associate’ if
the response was not a true autobiographical memory,
or (5) ‘no response’. The AMT will be audio-recorded
and the responses co-rated.
9. Daily mood ratings and social connectedness.
Participants will be asked to rate ‘How [emotion]
they feel’ on a Likert scale from 1 (not at all) to 9
(extremely) and to specify who they are with
(family, friends, on my own, other: please specify).
Mood ratings will be taken to eight emotions
(happy, joyful, excited, energetic, sad, angry,
nervous, and upset). Participants will be asked to
install an app on their mobile phone and will be
prompted to complete the questions once per day
for 7 days pre-intervention and 7 days post-
intervention. This app prompts them to answer the
survey at the same time each day and also sends a
reminder for them to complete it if they have not
responded within an hour. If the app does not work
for certain participants’ phones, then alternative
methods will be used that best suit the participant
(for example, text messages).
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10. Memory recall task. A bespoke experimental task
will measure participants’ emotional response to
one positive autobiographical memory pre-
intervention and a different positive autobiograph-
ical memory post-intervention. Participants will be
asked to generate two positive autobiographical
memories before attending the first assessment ses-
sion and prior to randomisation. Emotional re-
sponse will be measured using subjective ratings of
mood (on the eight scales detailed above) as well as
using a more objective psychophysiological meas-
ure, heart rate variability (HRV, recorded with Polar
RCS800CX). This recall task was based on a recent
experimental task using processing mode to alter
positive emotional response [73].
Intervention development and development of training
materials
Throughout the trial, qualitative descriptions of the
treatment targets (e.g. negative images rescripted; posi-
tive future images generated) will be recorded. This will
allow refinement of the intervention manual following
trial completion and further development of training
materials for teaching practitioners how to deliver the
intervention.
Qualitative interviews
A small subset of trial participants will also be invited to
take part in qualitative interviews following completion
of their participation in the trial. These interviews will
be conducted, analysed and reported separately from the
main trial.
Analysis plan
Primary feasibility data will be presented descriptively as
outlined in the outcome measures section. Descriptive
statistics will be reported for all other relevant outcomes
at each time point by trial arm. This will include means
(standard deviations) and medians (interquartile range)
for normally and non-normally distributed variables, re-
spectively. Frequencies and percentages will be used to
summarise categorical data.
Additionally, for the secondary clinical and mechanis-
tic outcomes, we will present between-group mean dif-
ferences at the two follow-up time points in the form of
standardised effect sizes with 95% confidence intervals,
using both the intention-to-treat population (all partici-
pants randomised regardless of adherence to treatment)
and the per protocol population (only participants ad-
hering to treatment; defined as completing at least three
sessions).
Flow through the trial will also be presented in a stand-
ard CONSORT diagram, including number approached to
participate, number eligible/ineligible, number randomised,
drop-outs before the end of treatment and numbers
retained in the trial at 3-month follow-up.
Criteria for proceeding to a future trial
The decision of whether or not to proceed to a future
definitive trial will be based on the feasibility and accept-
ability data. Primarily, to proceed, it will be important
that recruitment for the current feasibility trial is achiev-
able within a reasonable amount of time (2 years for full
recruitment), retention rates are at least 80% at post-
intervention and 70% at 3-months and an average ac-
ceptability of the ICBI intervention is rated as satisfac-
tory or above. Not reaching these criteria does not
necessarily indicate unfeasibility of a future definitive
trial but may underline changes needed to the trial
protocol, which will also be informed by qualitative find-
ings regarding reasons for participation and any experi-
ences of intervention which may impact upon retention
or acceptability of the ICBI intervention. This would also
be reviewed by the trial steering committee (TSC). Fur-
thermore, any serious adverse events, serious adverse re-
actions or suspected unexpected serious adverse
reactions that arise will be carefully reviewed by the
TSC, and their advice will be followed on whether these
would preclude proceeding to a definitive trial.
Monitoring
Trial steering committee
A TSC has been formed. The TSC’s role is to provide
oversight of trial progress and conduct (including adher-
ence to protocol) and provide guidance for appropriate
aspects of the trial. This includes monitoring and super-
vising the progress of the trial towards its interim and
overall objectives and monitoring the rights, safety and
well-being of the participants. Given the scope and
nature of the trial, a data monitoring committee was not
deemed necessary.
Criteria for discounting or modifying intervention for a
given participant
The interventions will be discontinued for a given trial
participant if adverse events are reported that are
deemed to be associated with the intervention by the
chief investigator (CI), supervisors and/or independent
chair. The content of both the interventions will be tai-
lored to the individual needs of the individual, whilst
remaining consistent with the manuals.
Adverse events
Serious adverse events (SAE: events not necessarily
caused by or related to the intervention), serious adverse
reactions (SAR: events related to any duration of inter-
vention administered to that person) and suspected un-
expected serious adverse reaction (SUSAR: an adverse
Pile et al. Pilot and Feasibility Studies  (2018) 4:97 Page 9 of 13
reaction where nature and severity of which is not con-
sistent with the information known about the interven-
tion in question in the view of the investigator) are
defined as events that result in death, are life-
threatening, require hospitalisation or prolongation of
existing hospitalisation, result in persistent or significant
disability or incapacity, or consist of a congenital anom-
aly or birth defect. All SARs and SUSARs will be re-
ported immediately by the CI to the ethics committee
within 15 days of the CI becoming aware of the event.
Adverse events (AE) (any untoward medical occur-
rence in a subject to whom an intervention has been ad-
ministered including occurrences, which are not
necessarily caused by or related to that therapy) will be
monitored and recorded from randomisation to the final
follow-up (3-month follow-up). As the trial will be con-
ducted within a school setting with participants who are
reporting symptoms of depression, possible AE that are
likely in this population and will not be reported to the
TSC are low-risk acts of self-harm (not requiring med-
ical attention), e.g. minor scratching. Possible AE and
serious adverse events (SAE) that are less likely but may
still occur include high-risk acts of self-harm (requiring
medical attention, but not medical hospital admission)
and death by suicide. These will be reported to the inde-
pendent chair of the TSC. Any adverse events that are
considered by the CI, in consultation with the independ-
ent chair of the TSC, to be related to trial procedures in
any way, or are unexpected, will be reported in timely
fashion as stipulated above. These AE and SAE will be
recorded and reported in full in the trial report and jour-
nal paper. In addition, risk and health service use will be
assessed at each assessment time point, and a risk-
monitoring question will be completed at each interven-
tion session. The participant information sheet also con-
tains information about who to contact if the participant
feels that the study has harmed them in any way or if
they wish to make a complaint about the conduct of
the study.
Stopping guidelines The trial may be prematurely dis-
continued by the Sponsor (The Director of Research
Management and Innovation, King’s College London) or
CI based on new safety information or for other reasons
given by the ethics committee or TSC. If there is one ad-
verse event, then the independent chair will be con-
tacted; two adverse events and the TSC will be
contacted; if there are three adverse events in a row then
the trial would be paused to reflect and identify the
problems, and the TSC would be contacted. The trial
may also be prematurely discontinued due to lack of re-
cruitment or upon advice from the TSC, who will advise
on whether to continue or discontinue the study. If the
study is prematurely discontinued, active participants
will be informed. Next steps will be agreed upon in con-
sultation with the independent chair; it is most likely
that data collection would continue but that participants
would no longer receive the intervention.
Data management, modifications and publication
Participant data will be anonymised. Participants will be
identified on the study database using a unique code and
initials. All anonymised data will be stored on a
password-protected computer and backed up regularly.
All trial data will be handled, computerised and stored
in line with the Data Protection Act, 1998 and archived
in line with the Sponsor requirements. To assess data
entry quality, the data will be checked using range
checks and a small proportion of the entered data (10%)
will be compared to the raw data by a member of the
team blind to participant allocation. Further checks will
be completed if necessary. Any modifications to the pro-
tocols (e.g. changes to eligibility criteria or assessments)
will be reported to the relevant parties (e.g. ethics com-
mittee, TSC, ISRCTN) in a timely manner. It is intended
that the results of the study will be reported and dissem-
inated at the local level and more widely at national and
international conferences and through publication in
peer-reviewed scientific journals. The dataset will also be
made publicly available following the completion of the
trial.
Service user involvement
Service user consultation has been integrated into the
development of the intervention, the trial design and the
trial protocol. Service user advisory groups were con-
sulted during the development of the project and their
recommendations incorporated. Two key examples of
how service user consultation has influenced the design
of the project were recommendations to have the inclu-
sion criteria as young people with symptoms of depres-
sion (rather than a depression diagnosis) and delivering
the intervention in schools (rather than in NHS clinics).
Service users have been very positive about the aims of
the trial, identifying a serious, unmet need for young
people with depression, and a lack of clarity on what in-
terventions could be offered. Two service user consul-
tants have been recruited to provide consultation
throughout the trial and to input on the TSC.
Discussion
Here, we describe a feasibility RCT for a brief early inter-
vention for adolescent depression. The intervention is
anchored in cognitive science, developed in consultation
with service users and designed to be delivered in sec-
ondary schools. The intervention aims to build positive
future mental imagery, process distressing past negative
imagery and improve specificity of autobiographical
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memories. These processes have been implicated in the
development and maintenance of depression but have
not previously been combined in a treatment package,
such as this with an imagery focus.
A strength of the trial is that it can be readily scaled up
into a definitive trial, should it be shown to be feasible, ac-
ceptable and safe. This includes collecting data on mea-
sures that assess mechanisms as these are important for a
definitive trial to understand whether the active ingredi-
ents of the intervention are those proposed. Furthermore,
a strength of the design is in the inclusion of an active
control intervention: NDST. The control group in similar
trials usually receive ‘no intervention’ or ‘waitlist’ condi-
tion (e.g. none of the indicated programmes reviewed by
Calear and Christensen [8] received an active control).
Given that change could be driven by factors related to
non-specific aspects of therapy (e.g. speaking to an em-
pathic therapist), it seems vital to include a control group
that reflects what young people with depressive symptoms
could receive in school from a school counsellor. How-
ever, the inclusion of such a group delivered by the first
author also represents a weakness of the study. This con-
trol condition was chosen to reflect recommendations in
NICE guidelines and ethical considerations of offering an
appropriate intervention to young people with high symp-
toms of depression, and to ensure consistency within the
control group. However, there is huge variability in the in-
terventions delivered in schools to young people with high
symptoms of depression as well as the availability of an
intervention. Therefore, our control group perhaps re-
flects the upper end of what young people with high
symptoms of depression are likely to receive as it is both a
NICE recommended intervention and will be offered to
all participants.
The design and methods proposed are commensurate
with recommendations for feasibility studies [74], for ex-
ample, being consistent with the guidelines provided by
the National Institute for Health Research Trials and Stud-
ies (NETSCC). This feasibility study has been designed to
enable us to test uncertainties that would arise when pre-
paring for and undertaking a large-scale fully powered
RCT of IBCI vs NDST. This trial will allow us to optimise
both the intervention and the future trial design.
Conclusion
The aim of this feasibility RCT is to determine whether
an efficacy RCT is indicated and to aid the planning of
such a trial. If the intervention is found to be feasible,
acceptable and safe, then a future trial could test
whether it is clinically and cost-effective. This could help
improve the intervention options for young people with
symptoms of depression, offering a novel early interven-
tion for the early stages of adolescent depression.
Abbreviations
AE: Adverse events; AMT: Autobiographical memory task; CBT: Cognitive
behavioural therapy; CI: Chief investigator; C-RSQ: Children’s Response Style
Questionnaire; ICBI: Imagery-based cognitive behavioural intervention;
IMAGINE: Integrating Memories and Generating Images of New Experiences;
KCTU: King’s Clinical Trials Unit; MFQ: Mood and Feelings Questionnaire;
NDST: Non-directive supportive therapy; OGM: Overgeneral memory;
PIT: Prospective Imagery Task; RCT: Randomised controlled trial; RIES-
C: Revised Impact of Event Scale: child version; RSES: Rosenberg Self Esteem
Scale; SAE: Serious adverse events; SAR: Serious adverse reactions;
SCARED: Screen for Child Anxiety Related Disorders; SCCS: Self-Concept
Clarity Scale; SUSAR: Suspected unexpected serious adverse reaction;
TSC: Trial steering committee; UK: United Kingdom; VP: Victoria Pile
Acknowledgements
We are very grateful to the members of our Trial Steering Committee,
including Professor Shirley Reynolds who is the independent chair and
Margaret Ogden and Laura Schlepper, our service-user representatives. We
are also grateful to the King’s Clinical Trial Unit for their ongoing general and
statistical advice for the trial and for their randomisation services.
Funding
This study represents independent research from a Clinical Doctoral Research
Fellowship (Dr Victoria Pile, ICA-CDRF-2015-01-007) supported by the National
Institute for Health Research and Health Education England. The views
expressed in this publication are those of the authors and not necessarily those
of the NHS, NIHR, Health Education England or the Department of Health.
Availability of data and materials
It is planned to make individual participant data available on publication of
the associated study results, via a publicly available data repository such as
Open Science Framework. Data made available will be the research data
reported in the publication, with the exception of any data that could
compromise participant anonymity.
It is planned to make study-specific materials publicly available, via a reposi-
tory such as Open Science Framework, with the exception of those subject
to copyright or intellectual property restrictions which will be made available
upon request from the authors.
Authors’ contributions
All authors contributed to the design of the trial and trial protocol. VP wrote
the first draft of the manuscript. All authors read, contributed to and
approved the final manuscript.
Ethics approval and consent to participate
Ethical approval was obtained from the Psychiatry, Nursing and Midwifery
Research Ethics Committee at Kings College London (ref: HR-16/17-3548). All
participants will provide informed written consent. The trial will be conducted
in compliance with the principles of the Declaration of Helsinki (1996),
the principles of GCP. The chief investigator will submit annual reports
and a final report at conclusion of the trial to the funder.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Psychology, Institute of Psychiatry, Psychology and
Neuroscience, King’s College London, De Crespigny Park, London SE5 8AF,
UK. 2Florence Nightingale Faculty of Nursing and Midwifery, King’s College
London, London, UK. 3Mental Health Research and Treatment Center,
Department of Psychology, Ruhr-Universität Bochum, Bochum, Germany.
4Department of Clinical Psychology, University of East Anglia, Norwich, UK.
5Mood Disorders Centre, University of Exeter, Exeter, UK. 6Department for
Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden. 7Department
of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and
Neuroscience, King’s College London, London, UK.
Pile et al. Pilot and Feasibility Studies  (2018) 4:97 Page 11 of 13
Received: 20 October 2017 Accepted: 2 May 2018
References
1. Kuyken W, Dalgleish T. Overgeneral autobiographical memory in
adolescents at risk for depression. Memory. 2011;19:241–50.
2. Richards D. Prevalence and clinical course of depression: a review.
Clin Psychol Rev. 2011;31:1117–25.
3. de Girolamo G, Dagani J, Purcell R, Cocchi A, McGorry PD. Age of onset of
mental disorders and use of mental health services: needs, opportunities
and obstacles. Epidemiol Psychiatr Sci. 2012;21:47–57.
4. Andersen SL, Teicher MH. Stress, sensitive periods and maturational events
in adolescent depression. Trends Neurosci. 2008;31:183–91.
5. Fombonne E, Wostear G, Cooper V, Harrington R, Rutter M. The Maudsley
long-term follow-up of child and adolescent depression: 2. Suicidality,
criminality and social dysfunction in adulthood. Br J Psychiatry.
2001;179:218–23.
6. Zisook S, Rush AJ, Lesser I, Wisniewski SR, Trivedi M, Husain MM, et al.
Preadult onset vs. adult onset of major depressive disorder: a replication
study. Acta Psychiatr Scand. 2007;115:196–205.
7. Health Committee, House of Commons. Children’s and adolescents’ mental
health and CAMHS. London: The Stationery Office; 2014.
8. Calear AL, Christensen H. Systematic review of school-based prevention and
early intervention programs for depression. J Adolesc. 2010;33:429–38.
9. Barrett P, Pahl KM. School-based intervention: examining a universal
approach to anxiety management. Aust J Guid Couns. 2006;16:55–75.
10. Masia-Warner C, Nangle D, Hansen D. Bringing evidence-based child mental
health services to the schools: general issues and specific populations.
Educ Treat Child. 2006;29:165–72.
11. Holmes EA, Mathews A. Mental imagery in emotion and emotional
disorders. Clin Psychol Rev. 2010;30:349–62.
12. Morina N, Deeprose C, Pusowski C, Schmid M, Holmes EA. Prospective
mental imagery in patients with major depressive disorder or anxiety
disorders. J Anxiety Disord. 2011;25:1032–7.
13. Holmes EA, Lang TJ, Moulds ML, Steele AM. Prospective and positive mental
imagery deficits in dysphoria. Behav Res Ther. 2008;46:976–81.
14. Meiser-Stedman R, Dalgleish T, Yule W, Smith P. Intrusive memories and
depression following recent non-traumatic negative life events in
adolescents. J Affect Disord. 2012;137:70–8.
15. Holmes EA, Blackwell SE, Heyes SB, Renner F, Raes F. Mental imagery in
depression: phenomenology, potential mechanisms, and treatment
implications. Annu Rev Clin Psychol. 2016;12:249–80.
16. Kosslyn SM, Ganis G, Thompson WL. Neural foundations of imagery. Nat Rev
Neurosci. 2001;2:635–42.
17. Stober J. Prospective cognitions in anxiety and depression: replication and
methodological extension. Cogn Emot. 2000;9931:37–41.
18. MacLeod AK, Byrne A. Anxiety, depression, and the anticipation of future
positive and negative experiences. J Abnorm Psychol. 1996;105:286.
19. Williams JMG, Barnhofer T, Crane C, Herman D, Raes F, Watkins E, et al.
Autobiographical memory specificity and emotional disorder. Psychol Bull.
2007;133:122–48.
20. Dalgleish T, Werner-Seidler A. Disruptions in autobiographical memory
processing in depression and the emergence of memory therapeutics.
Trends Cogn Sci. 2014;18:596–604.
21. Brewin CR, Wheatley J, Patel T, Fearon P, Hackmann A, Wells A, et al.
Imagery rescripting as a brief stand-alone treatment for depressed patients
with intrusive memories. Behav Res Ther. 2009;47:569–76.
22. Korrelboom K, Maarsingh M, Huijbrechts I. Competitive memory training
(COMET) for treating low self-esteem in patients with depressive disorders:
a randomised clinical trial. Depress Anxiety. 2012;29:102–10.
23. Wild J, Hackmann A, Clark DM. Rescripting early memories linked to
negative images in social phobia: a pilot study. Behav Ther. 2008;39:47–56.
24. Hitchcock C, Werner-Seidler A, Blackwell SE, Dalgleish T. Autobiographical
episodic memory-based training for the treatment of mood, anxiety and
stress-related disorders: a systematic review and meta-analysis. Clin Psychol
Rev. 2017;52:92–107.
25. Blackwell SE, Browning M, Mathews A, Pictet A, Welch J, Davies J, et al.
Positive imagery-based cognitive bias modification as a web-based
treatment tool for depressed adults: a randomized controlled trial.
Clin Psychol Sci. 2015;3:91–111.
26. Morina N, Lancee J, Arntz A. Imagery rescripting as a clinical intervention for
aversive memories: a meta-analysis. J Behav Ther Exp Psychiatry. 2017;55:6–15.
27. Burnett Heyes S, Lau JYF, Holmes EA. Mental imagery, emotion and
psychopathology across child and adolescent development. Dev Cogn
Neurosci. 2013;5:119–33.
28. Salmon K, Bryant RA. Posttraumatic stress disorder in children: the influence
of developmental factors. Clin Psychol Rev. 2002;22:163–88.
29. Meiser-Stedman R. Towards a cognitive–behavioral model of PTSD in
children and adolescents. Clin Child Fam Psychol Rev. 2002;5:217–32.
30. Lereya ST, Copeland WE, Costello EJ, Wolke D. Adult mental health
consequences of peer bullying and maltreatment in childhood: two cohorts
in two countries. Lancet Psychiatry. 2015;2:524–31.
31. Hackmann A, Clark DM, McManus F. Recurrent images and early memories
in social phobia. Behav Res Ther. 2000;38:601–10.
32. Lau JYF. Cognitive bias modification of interpretations: a viable treatment
for child and adolescent anxiety? Behav Res Ther. 2013;51:614–22.
33. Lau JYF, Pile V. Can cognitive bias modification of interpretations training
alter mood states in children and adolescents? A reanalysis of data from six
studies. Clin Psychol Sci. 2015;3:112–25.
34. Post M. Transduction of psychosocial stress into the neurobiology of
recurrent affective disorder. Am J Psychitary. 1992;149(8):999–1010.
35. Sokolov S, Kutcher S. Adolescent depression: neuroendocrine aspects. In:
Goodyer IM, editor. The depressed child and adolescent, Cambridge child
and adolescent psychiatry series. Cambridge: Cambridge University Press;
2001. p. 233–66.
36. Conway MA, Pleydell-Pearce CW. The construction of autobiographical
memories in the self-memory system. Psychol Rev. 2000;107:261–88.
37. Williams JMG, Ellis NC, Tyers C, Healy H, Rose G, Macleod AK. The specificity
of autobiographical memory and imageability of the future. Mem Cogn.
1996;24:116–25.
38. Hitchcock C, Nixon RDV, Weber N. A review of overgeneral memory in child
psychopathology. Br J Clin Psychol. 2014;53:170–93.
39. van Minnen A, Wessel I, Verhaak C, Smeenk J. The relationship between
autobiographical memory specificity and depressed mood following a
stressful life event: a prospective study. Br J Clin Psychol. 2005;44:405–15.
40. Gibbs BR, Rude SS. Overgeneral autobiographical memory as depression
vulnerability. Cogn Ther Res. 2004;28:511–26.
41. Valentino K, Toth SL, Cicchetti D. Autobiographical memory functioning
among abused, neglected, and nonmaltreated children: the overgeneral
memory effect. J Child Psychol Psychiatry. 2009;50:1029–38.
42. Kleim B, Ehlers A. Reduced autobiographical memory specificity predicts
depression and posttraumatic stress disorder after recent trauma. J Consult
Clin Psychol. 2008;76:231–42.
43. Spinhoven P, Bockting CLH, Schene AH, Koeter MWJ, Wekking EM, Williams
JMG. Autobiographical memory in the euthymic phase of recurrent
depression. J Abnorm Psychol. 2006;115:590–600.
44. Raes F, Williams JMG, Hermans D. Reducing cognitive vulnerability to
depression: a preliminary investigation of MEmory Specificity Training
(MEST) in inpatients with depressive symptomatology. J Behav Ther Exp
Psychiatry. 2009;40:24–38.
45. Neshat-Doost HT, Dalgleish T, Yule W, Kalantari M, Ahmadi SJ, Dyregrov A,
et al. Enhancing autobiographical memory specificity through cognitive
training: an intervention for depression translated from basic science. Clin.
Psychol Sci. 2012;1:84–92.
46. Burleson Daviss W, Birmaher B, Melhem NA, Axelson DA, Michaels SM, Brent
DA. Criterion validity of the Mood and Feelings Questionnaire for depressive
episodes in clinic and non-clinic subjects. J Child Psychol Psychiatry Allied
Discip. 2006;47:927–34.
47. Smith P, Scott R, Eshkevari E, Jatta F, Leigh E, Harris V, et al. Computerised
CBT for depressed adolescents: randomised controlled trial. Behav Res Ther.
2015;73:104–10.
48. Wright B, Tindall L, Littlewood E, Adamson J, Allgar V, Bennett S, et al.
Computerised cognitive behaviour therapy for depression in adolescents: study
protocol for a feasibility randomised controlled trial. BMJ Open. 2014;4:e006488.
49. Julious SA. Sample size of 12 per group rule of thumb for a pilot study.
Pharm Stat. 2005;4:287–91.
50. Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies:
recommendations for good practice. J Eval Clin Pract. 2004;10:307–12.
51. Sim J, Lewis M. The size of a pilot study for a clinical trial should be
calculated in relation to considerations of precision and efficiency. J Clin
Epidemiol. 2012;65:301–8.
Pile et al. Pilot and Feasibility Studies  (2018) 4:97 Page 12 of 13
52. MHRA. Good clinical practice guide. London: The Stationery Office; 2012.
53. Wild J, Clark DM. Imagery rescripting of early traumatic memories in social
phobia. Cogn Behav Pract. 2011;18:433–43.
54. Frets PG, Kevenaar C, van der Heiden C. Imagery rescripting as a stand-
alone treatment for patients with social phobia: a case series. J Behav Ther
Exp Psychiatry. 2014;45:160–9.
55. Birmaher B, Brent DA, Kolko D, Baugher M, Bridge JA, Holder D, et al.
Clinical outcome after short-term psychotherapy for adolescents with major
depressive disorder. Arch Gen Psychiatry. 2000;57:29–36.
56. Cuijpers P, Driessen E, Hollon SD, van Oppen P, Barth J, Andersson G. The
efficacy of non-directive supportive therapy for adult depression: a meta-
analysis. Clin Psychol Rev. 2012;32:280–91.
57. National Institute of Clinical Excellence. CG28 depression in children and
young people: full guidance. 2015. Available at http://guidance.nice.org.uk/
CG28/Guidance.
58. Vallis TM, Shaw BF, Dobson KS. The cognitive therapy scale: psychometric
properties. J Consult Clin Psychol. 1986;54:381–5.
59. Angold A, Costello EJ, Messer SC, Pickles A, Winder F, Silver D. The
development of a short questionnaire for use in epidemiological studies of
depression in children and adolescents. Int J Methods Psychiatr Res. 1995:
237–49.
60. Birmaher B, Khetarpal S, Brent D, Cully M, Balach L, Kaufman J, et al. The
screen for child anxiety related emotional disorders (SCARED): scale
construction and psychometric characteristics. J. Am. Acad. Child Adolesc.
Psychiatry. The Am Acad Child Adolesc Psychiatry; 1997;36:545–553.
61. Muris P, Merckelbach H, Mayer B, Van Brakel A, Thissen S, Moulaert V, et al.
The Screen for Child Anxiety Related Emotional Disorders (SCARED) and
traditional childhood anxiety measures. J Behav Ther Exp Psychiatry 1998;
29(4):327–39.
62. Perrin S, Meiser-Stedman R, Smith P. The Children’s Revised Impact of Event
Scale (CRIES): validity as a screening instrument for PTSD. Behav Cogn
Psychother. 2005;33:487.
63. Smith P, Perrin S, Yule W, Rabe-Hesketh S. War exposure and maternal
reactions in the psychological adjustment of children from Bosnia-
Hercegovina. J Child Psychol Psychiatry. 2001;42:395–404.
64. Abela JRZ, Vanderbilt E, Rochon A. A test of the integration of the response
styles and social support theories of depression in third and seventh grade
children. J Soc Clin Psychol. 2004;23:653–74.
65. Hamlat EJ, Connolly SL, Hamilton JL, Stange JP, Abramson LY, Alloy LB.
Rumination and overgeneral autobiographical memory in adolescents: an
integration of cognitive vulnerabilities to depression. J Youth Adolesc. 2015;
44:806–18.
66. Rosenberg M. Society and the adolescent self-image. Princeton: Princeton
University Press; 1965.
67. Bos AER, Huijding J, Muris P, Vogel LRR, Biesheuvel J. Global, contingent and
implicit self-esteem and psychopathological symptoms in adolescents.
Personal Individ Differ. 2010;48:311–6.
68. Butler RJ, Gasson SL. Self esteem/self concept scales for children and
adolescents: a review. Child Adolesc Ment Health. 2005;10:190–201.
69. Colman I, Zeng Y, McMartin SE, Naicker K, Ataullahjan A, Weeks M, et al.
Protective factors against depression during the transition from adolescence
to adulthood: findings from a national Canadian cohort. Prev Med (Baltim).
2014;65:28–32.
70. Campbell JD, Trapnell PD, Heine SJ, Katz IM, Lavallee LF, Lehman DR.
Self-concept clarity: measurement, personality correlates, and cultural
boundaries. J Pers Soc Psychol. 1996;70:141–56.
71. Chang EC. Life stress and depressed mood among adolescents: examining
a cognitive-affective mediation model. J Soc Clin Psychol. 2001;20:416–29.
72. Williams JMG, Broadbent K. Autobiographical memory in suicide attempters.
J Abnorm Psychol. 1986;95:144–9.
73. Gadeikis D, Bos N, Schweizer S, Murphy F, Dunn B. Engaging in an experiential
processing mode increases positive emotional response during recall of
pleasant autobiographical memories. Behav Res Ther. 2017;92:68–76.
74. Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility
study? A review of current practice and editorial policy. BMC Med Res
Methodol. 2010;10:67.
Pile et al. Pilot and Feasibility Studies  (2018) 4:97 Page 13 of 13
